Dudley Robert E. 4
4 · Clarus Therapeutics Holdings, Inc. · Filed Sep 13, 2021
Insider Transaction Report
Form 4
Dudley Robert E.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2021-09-09+4,566→ 4,566 total
Footnotes (1)
- [F1]Received pursuant to the Agreement and Plan of Merger, dated as of April 27, 2021 by and among Blue Water Acquisition Corp. (n/k/a Clarus Therapeutics Holdings, Inc.) (the "Issuer"), Blue Water Merger Sub Corp. and Clarus Therapeutics, Inc. ("Legacy Clarus") (the "Merger Agreement") pursuant to which, through a merger, Legacy Clarus became a direct, wholly-owned subsidiary of the Issuer.